Search Results 31-40 of 14186 for Giant cell arteritis
Polymyalgia Rheumatica; Giant Cell Arteritis; Behcet's Disease; Granulomatosis with Polyangiitis (Wegener's Granulomatosis); Henoch-Schonlein Purpura (IgA ...
The purpose of this study is to determine the effectiveness of abatacept in Giant Cell Arteritis (GCA). Patients who have newly diagnosed or relapsing GCA ...
Giant cell arteritis (GCA), formerly known as temporal arteritis, was first described by Mayo doctors and classified as an inflammatory condition of the ...
Treatment for giant cell arteritis has historically been glucocorticoid (steroid) therapy. To jump-start Cori's recovery, she immediately began taking daily ...
... giant cell arteritis and Takayasu arteritis. Arthritis & Rheumatology. 2021; doi:10.1002/art.41774. AskMayoExpert. Takayasu arteritis. Mayo Clinic; 2024 ...
Relapse Prediction Following Discontinuation of Tocilizumab In Giant Cell Arteritis · More about research at Mayo Clinic · Mayo Clinic Footer.
Temporal artery biopsy revealing features of giant cell arteritis; Evidence of large-vessel vasculitis. New onset active disease with diagnosis within 6 weeks ...
Mayo Clinic researchers have identified key protein patterns in the blood that could improve how doctors diagnose and monitor giant cell arteritis, a chronic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.